$109.550
-0.427 (-0.39%)Zum Schluss
KMB-News
KMB-Events
Stocks Broadly Lower Following Fed Chair Speech
Stocks ended the day broadly lower following Federal Reserve Chair Kevin Warsh's speech at the Jackson Hole symposium. In his first major speech since taking the chair in May, Warsh warned that inflation has not meaningfully slowed, signaling that policymakers may have "work to do" to bring inflation back down to the Fed's 2% target.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Advent and Stripe are no longer pursuing a $50B deal for PayPal,Marvellreportedand provided guidance for Q3Gapprovided a "beat and raise" report for Q2Element Solutionsand Solstice Advanced Materialsmutually agreed toGE Vernovanamed Rivian's2. WALL STREET CALLS:Modernato Buy at Argus after FDA approval for updated Covid vaccinesWorkdayto Equalweight at Capital OneTeraWulfwith an Outperform at William BlairEvolution Petroleumto Outperform at NorthlandAllstateto Hold at Argus3. AROUND THE WEB:The U.S. appeals court sided with Nevada regulators, allowing the state to treat sports prediction markets like unlicensed sportsbooks, while sending Kalshi's election contracts back for further consideration, Bloomberg Law reportsChevronappears positioned to invest billions of dollars and expand its Venezuela footprint, while Halliburtoncould benefit from increased oilfield services activity, WSJ reportsAnthropic discussed buying AI chip startup MatX for about $7B, but talks are no longer active, Reuters saysKimberly-Clarkhas asked EU regulators permission for its proposed $40B takeover of Kenvue, Reuters reportsSoftBankis in talks to buy a majority stake in humanoid robot maker 1X at a $6B valuation, The Information says4. MOVERS:Elasticadvanced after, providing guidance for Q2, and raising its outlook for FY27PagerDutygained afterand raising its guidance for FY27N-ablewas higher after announcing a $50M increase to itsRubrikfell afterand raising its guidance for FY27BioNTechwas lower in New York after announcing it will terminate its5. EARNINGS/GUIDANCE:Chase, with EPS beating consensusFiscalNoteprovidedMiniso, with CEO Guofu Ye "pleased to see that MINISO Chinese mainland delivered a standout performance"Koss Corp., with EPS and revenue higher year-over-yearAffirmand provided guidance for Q1 and FY27INDEXES:The Dow fell 9.45, or 0.02%, to 53,559.99, the Nasdaq lost 138.93, or 0.52%, to 26,402.42, and the S&P 500 declined 19.23, or 0.25%, to 7,711.76.
Major Averages Rise After Fed Chair's Speech
The major averages were higher near noon after Federal Reserve Chair Kevin Warsh's speech at the Jackson Hole symposium. In his first major speech since taking the chair in May, Warsh warned that inflation has not meaningfully slowed, signaling that policymakers may have "work to do" to bring inflation back down to the Fed's 2% target.The Treasury market remains a risk as long-term yields have risen sharply in recent weeks, with the 30-year yield near levels last seen in 2007. Treasury Secretary Scott Bessent's expanded bond-buyback program has attempted to ease pressure at the long end of the curve, but investors remain concerned about inflation, government borrowing and the fiscal outlook.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Advent and Stripe are no longer pursuing a $50B deal for PayPal,Marvellreportedand provided guidance for Q3Gapprovided afor Q2Element Solutionsand Solstice Advanced Materialsmutually agreed toGE Vernovanamed Rivian's2. WALL STREET CALLS:Modernato Buy at Argus after FDA approval for updated Covid vaccinesWorkdayto Equalweight at Capital OneTeraWulfwith an Outperform at William BlairEvolution Petroleumto Outperform at NorthlandAllstateto Hold at Argus3. AROUND THE WEB:Chevronappears positioned to invest billions of dollars and expand its Venezuela footprint, with a potential addition of two heavy-oil fields, while Halliburtoncould benefit from increased oilfield services activity, WSJ reportsAnthropic discussed buying AI chip startup MatX for about $7B, but talks are no longer active, Reuters saysKimberly-Clarkhas asked EU regulators permission for its proposed $40B takeover of Kenvue, Reuters reportsSoftBankis in talks to buy a majority stake in humanoid robot maker 1X at a $6B valuation, The Information saysYouTubeand TikTok are yet to publicly acknowledge Meta'sproposed changes under its AG settlement, NY Times reports4. MOVERS:Elasticincreases after, providing guidance for Q2, and raising its outlook for FY27PagerDutygains afterand raising its guidance for FY27N-ablehigher after announcing a $50M increase to itsRubrikfalls afterand raising its guidance for FY27BioNTechlower in New York after announcing it will terminate itsof a cancer vaccine5. EARNINGS/GUIDANCE:Chasewith EPS beating consensusFiscalNoteMiniso, with CEO Guofu Ye "pleased to see that MINISO Chinese mainland delivered a standout performance"Koss Corp., with EPS and revenue higher year-over-yearAffirmand provided guidance for Q1 and FY27INDEXES:Near midday, the Dow was up 94.13, or 0.18%, to 53,663.57, the Nasdaq was up 51.28, or 0.19%, to 26,592.63, and the S&P 500 was up 16.06, or 0.21%, to 7,747.05.
Kimberly-Clark Appoints Suzana Blades as SVP and General Counsel
Kimberly-Clark (KMB) announced the appointment of Suzana Blades as Senior Vice President and General Counsel, effective September 1. She will report to Jeff Melucci, Chief Strategy, Business Development and Administrative Officer, and will become a member of Kimberly-Clark's Executive Leadership Team. Blades has also been named to the leadership team that will take effect upon completion of Kimberly-Clark's pending acquisition of Kenvue (KVUE). Prior to joining Kimberly-Clark, Blades spent nearly 12 years at ConocoPhillips (COP).
Company's Q2 Diaper Sales Impacted by False Allegations
The company said, "The Company also noted that its second-quarter results were negatively impacted by a discrete disruption stemming from false allegations regarding the quality of certain diaper brands in the China market. Independent testing conducted by a government-certified third party confirmed the quality and safety of the Company's products, refuting the false allegations. While the Company is effectively navigating the situation, the impact from the spread of false claims across social media significantly impacted the Company's diaper sales in China in the second quarter and is expected to further impact sales and profits in the near term."
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.









